Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
106 USD | -0.26% | -0.94% | -3.82% |
04-29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
04-26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.82% | 184B | |
-2.22% | 107B | |
-4.48% | 67.52B | |
+1.06% | 50.06B | |
+9.87% | 45.67B | |
+3.40% | 41B | |
+3.54% | 26.73B | |
+4.12% | 26.47B | |
+15.23% | 25.05B | |
-2.63% | 24.56B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Abbott Laboratories : Says MitraClip Device to Receive Expanded Medicare Reimbursement